Edition:
United States

Cyclacel Pharmaceuticals Inc (CYCC.OQ)

CYCC.OQ on NASDAQ Stock Exchange Capital Market

0.74USD
18 Dec 2018
Change (% chg)

-- (--)
Prev Close
$0.74
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
21,779
52-wk High
$1.93
52-wk Low
$0.71

Chart for

About

Cyclacel Pharmaceuticals, Inc. operates in the field of cell cycle biology. The Company has generated various families of anticancer drugs that act on the cell cycle, including nucleoside analogs, cyclin dependent kinase (CDK) inhibitors, polo-like kinase (PLK) inhibitors and Aurora Kinase/vascular endothelial growth factor... (more)

Overall

Beta: 3.39
Market Cap(Mil.): $11.12
Shares Outstanding(Mil.): 12.50
Dividend: --
Yield (%): --

Financials

  CYCC.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -0.63 -- --
ROI: -35.44 0.60 13.80
ROE: -37.47 -2.18 15.29

Earnings vs. Estimates